引用本文: | 程颖, 张良. 帕博利珠单抗联合化疗对亚洲PD-L1阴性的晚期非小细胞肺癌患者的疗效与安全性[J]. 循证医学, 2023, 23(4): 213-224. DOI: 10.12019/j.issn.1671-5144.2023.04.005 |
Citation: | CHENG Ying, ZHANG Liang. Efficacy and Safety of Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor PD-L1 Expression in Asian Patients[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 213-224. DOI: 10.12019/j.issn.1671-5144.2023.04.005 |